Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
Annie Chan, Loh-Shan Leung, Mark S BlumenkranzDepartment of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USAAbstract: Macular edema is a common cause of visual loss in patients with retinal vein occlusions. Ozurdex®, a dexamethasone intravitreal implant, has been...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/8b8816c33df84f278ef61e305a1ab325 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:8b8816c33df84f278ef61e305a1ab325 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:8b8816c33df84f278ef61e305a1ab3252021-12-02T03:36:29ZCritical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion1177-54671177-5483https://doaj.org/article/8b8816c33df84f278ef61e305a1ab3252011-07-01T00:00:00Zhttp://www.dovepress.com/critical-appraisal-of-the-clinical-utility-of-the-dexamethasone-intrav-a7946https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Annie Chan, Loh-Shan Leung, Mark S BlumenkranzDepartment of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USAAbstract: Macular edema is a common cause of visual loss in patients with retinal vein occlusions. Ozurdex®, a dexamethasone intravitreal implant, has been shown in randomized controlled trials to reduce macular edema and improve visual acuity in patients with either branch retinal vein occlusions or central retinal vein occlusions. It was approved in the United States in 2009. Since then, new therapeutic agents and clinical data have emerged. The purpose of this review is to critically evaluate the clinical utility of Ozurdex® in the current treatment strategy of macular edema related to retinal vein occlusion.Keywords: macular edema, branch retinal vein occlusion, central retinal vein occlusion, dexamethasone, Ozurdex®Chan ALeung LSBlumenkranz MSDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 1043-1049 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Ophthalmology RE1-994 |
| spellingShingle |
Ophthalmology RE1-994 Chan A Leung LS Blumenkranz MS Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion |
| description |
Annie Chan, Loh-Shan Leung, Mark S BlumenkranzDepartment of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USAAbstract: Macular edema is a common cause of visual loss in patients with retinal vein occlusions. Ozurdex®, a dexamethasone intravitreal implant, has been shown in randomized controlled trials to reduce macular edema and improve visual acuity in patients with either branch retinal vein occlusions or central retinal vein occlusions. It was approved in the United States in 2009. Since then, new therapeutic agents and clinical data have emerged. The purpose of this review is to critically evaluate the clinical utility of Ozurdex® in the current treatment strategy of macular edema related to retinal vein occlusion.Keywords: macular edema, branch retinal vein occlusion, central retinal vein occlusion, dexamethasone, Ozurdex® |
| format |
article |
| author |
Chan A Leung LS Blumenkranz MS |
| author_facet |
Chan A Leung LS Blumenkranz MS |
| author_sort |
Chan A |
| title |
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion |
| title_short |
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion |
| title_full |
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion |
| title_fullStr |
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion |
| title_full_unstemmed |
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion |
| title_sort |
critical appraisal of the clinical utility of the dexamethasone intravitreal implant (ozurdex®) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion |
| publisher |
Dove Medical Press |
| publishDate |
2011 |
| url |
https://doaj.org/article/8b8816c33df84f278ef61e305a1ab325 |
| work_keys_str_mv |
AT chana criticalappraisaloftheclinicalutilityofthedexamethasoneintravitrealimplantozurdexampregforthetreatmentofmacularedemarelatedtobranchretinalveinocclusionorcentralretinalveinocclusion AT leungls criticalappraisaloftheclinicalutilityofthedexamethasoneintravitrealimplantozurdexampregforthetreatmentofmacularedemarelatedtobranchretinalveinocclusionorcentralretinalveinocclusion AT blumenkranzms criticalappraisaloftheclinicalutilityofthedexamethasoneintravitrealimplantozurdexampregforthetreatmentofmacularedemarelatedtobranchretinalveinocclusionorcentralretinalveinocclusion |
| _version_ |
1718401681053450240 |